SOLU-CORTEF
Google image searchProduct monograph
Active ingredient
hydrocortisone (hydrocortisone sodium succinate), 250 MG/VIAL
DIN: 00030619
Dosage form(s): POWDER FOR SOLUTION
Route(s) of administration: INTRAMUSCULAR, INTRAVENOUS
Description: SINGLE-DOSE ACT-O-VIAL
Schedule: Prescription
Company: PFIZER CANADA ULC
Date: 03-FEB-2009
ATC:
- H02 — CORTICOSTEROIDS FOR SYSTEMIC USE (ATC, ATC/DDD, )
- H02A — CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN (ATC, ATC/DDD)
- H02AB — Glucocorticoids (ATC, ATC/DDD)
- H02AB09 — HYDROCORTISONE (ATC/DDD)
Reference brand drug: Cortef
Pharmaceutical standard: USP
